Portola Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingCalifornia, United States51-200 Employees
Portola Pharmaceuticals is a mid-sized company focused on discovering, developing, and commercializing therapies for thrombosis and other hematologic conditions. Its first two marketed products are Andexxa, a recombinant coagulation factor Xa treatment, and Bevyxxa (betrixaban); Andexxa is marketed in Europe as Ondexxya (andexanet alfa). The company is based in South San Francisco, California, and maintains a pipeline that includes cerdulatinib, an investigational SYK/JAK inhibitor being developed for hematologic cancers.